世界银行-废旧铅酸蓄电池的回收利用：环境健康影响评估指南（英）-2021.11-132页_5mb

报告摘要

Summary of "Guidelines for the Sampling and Appraisal of Environmental Health Impacts of Toxic Contaminated Sites for the Recycling of Used Lead-Acid Batteries"

Core Content

This document provides guidelines for environmental and biological sampling to assess the health impacts of used lead-acid battery (ULAB) recycling activities in low- and middle-income countries (LMICs). It emphasizes the need for standardized, representative data collection to support environmental burden of disease evaluations, risk assessments, and economic-burden analyses. The guidelines aim to link environmental contamination with individual exposures and health outcomes in a structured and scientifically sound manner.

Main Objectives

To support environmental health assessments of ULAB sites in LMICs.
To provide a practical framework for sampling design and data collection.
To ensure comparability and standardization across different ULAB sites.
To assist in building local capacity for conducting environmental and health assessments.

Key Points

Environmental Health Impacts of Lead Exposure

Lead exposure has tragic and widespread consequences, with the 2019 Global Burden of Disease (GBD) report estimating over 900,000 deaths and 21.7 million years of healthy life lost (DALYs) globally due to lead exposure.
84-88% of lead-related health impacts have occurred in lower-middle and upper-middle-income countries since 1990.
Lead exposure is associated with neurodevelopmental effects in children, including reduced IQ, cognitive impairments, and behavioral issues.
Lead is also linked to adult health outcomes such as hypertensive heart disease, ischemic heart disease, stroke, and renal disorders.

Challenges in LMICs

Informal ULAB operations in LMICs often lack regulatory oversight and proper waste management, leading to direct environmental contamination.
Data collection on exposure factors and health outcomes is limited in LMICs, traditionally focused on high-income countries (HICs).
The uncertainty around exposure sources and their relationship to health outcomes poses a significant challenge in assessing the full impact of lead exposure.

Sampling Guidelines

Environmental Sampling

Soil: Collect four individual samples and analyze using in-field XRF. Composite samples should be sent to a laboratory for multi-metal screening. If resources allow, bioavailability testing for Pb should be conducted on 50% of household samples and 100% of targeted samples.
Dust: Collect two individual dust samples from interior surfaces using appropriate wipes (e.g., GhostWipe™). Analyze using in-field XRF, and composite samples should be sent to an accredited laboratory for multi-metal screening.
Water: Collect 1-liter samples at the point of use (e.g., household or communal water source). Samples can also be collected from off-site water bodies if they are commonly used. Send to an accredited laboratory for multi-metal screening.
Agricultural Products: Collect composite samples that reflect dietary habits of the largest number of participating households. Include meat, dairy, eggs, fruits, and vegetables. Samples should be collected from kitchen, garden, or market. Collect 40-100 grams of biomass based on laboratory guidance.

Biological Sampling

Biomarkers of exposure:
- Arsenic (As): Use metabolite monomethylarsonic acid (%MMA) from speciated creatinine-adjusted urine.
- Cadmium (Cd): Use creatinine-adjusted urine for biomarker analysis.
- Lead (Pb): Venous blood is the gold standard, with dried capillary blood spot using in-field LeadCare Analyzer as an alternative.
Biomarkers of effect:
- Lead: Measure blood pressure, proteinuria, anemia status, cardiovascular risk, and ALA. Conduct age-specific cognitive testing for children.
- Arsenic: Conduct age-specific cognitive testing, keratosis screening, and measure C-reactive protein as a non-specific biomarker.
- Cadmium: Measure urinary β2-microglobulin and glomerular filtration rate (GFR). Consider carcinogenic biomarkers if elevated.

Health Outcomes Assessment

Data should be linked to household survey data to understand the relationship between environmental contamination and health impacts.
Sample size recommendations are provided for each contaminant and environmental media.
Biomonitoring and health-outcome data should be compiled into country- or region-specific databases to support risk assessments and economic analyses.

Conceptual Site Model (CSM)

The CSM is a qualitative, graphical tool to understand the migration of contaminants, exposure pathways, and health outcomes.
It helps in identifying local hotspots and characterizing environmental contamination.
The general CSM serves as a starting point for developing site-specific models.

Sampling Design

A grid-based sampling design is recommended, with grid densities ranging from 20×20 m to 100×100 m, typically between 40×40 m and 60×60 m.
Household selection is done from each grid node.
Targeted sampling is advised for areas where individuals spend significant time (e.g., schools, playgrounds, agricultural locations).

Supporting Resources

The document includes appendices with additional resources on:
- Contaminants (e.g., lead, arsenic, cadmium).
- Home survey guidelines.
- Environmental sampling protocols.
- Biomonitoring resources.
- Health-outcomes assessment tools.
- Key references and bibliography.

Conclusion

The guidelines aim to support consistent and comparable community-risk and health-impact assessments in LMICs.
They provide a practical framework for sampling and analysis that is cost-effective and efficient.
Adherence to these guidelines will standardize data collection and facilitate meta-analyses across studies.

References

GBD 2019 Diseases and Injuries Collaborators (2020): Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019.
von Stackelberg et al. (2021): A Systematic Framework for Collecting Site-Specific Sampling and Survey Data to Support Analyses of Health Impacts from Land-Based Pollution in Low- and Middle-Income Countries.